UnitedHealthcare’s Remote Patient Monitoring Rollback: What It Means for Chronic Care Australians

UnitedHealthcare has pulled back its remote patient monitoring (RPM) coverage for most chronic conditions. The move strips away Medicare-aligned reimbursement for a service that was already sparking a shift in how doctors manage diabetes, COPD and heart failure at home.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.

What is RPM

In my experience around the country, remote patient monitoring (RPM) is any technology that lets a clinician track a patient’s vital signs, activity levels or medication adherence from a distance. Think Bluetooth-enabled blood-pressure cuffs that ping data to a doctor’s dashboard, or smartphone apps that remind a heart-failure patient to weigh-in daily.

The Australian Digital Health Agency reports a 30% rise in telehealth utilisation since 2020, and RPM is the next logical step. The US market, as outlined by Market Data Forecast, projects global RPM revenue to hit US$41 billion by 2033, a clear sign that health systems are betting on the tech.

RPM isn’t a one-size-fits-all gadget. It spans three tiers:

• Device-based monitoring: Wearables or home-based sensors that automatically transmit readings.
• App-driven tracking: Patients manually input data via a health app, which clinicians review.
• Deviceless RPM: Calls or video chats where clinicians assess symptoms without any hardware, a model gaining traction as a low-cost alternative.

Why does it matter? Chronic disease accounts for 90% of all health expenditure in Australia, according to the Australian Institute of Health and Welfare. By catching a deteriorating trend early, RPM can slash hospital admissions and keep patients out of the ER.

When the Centre for Medicare & Medicaid Services (CMS) introduced the Advanced Primary Care Management programme in 2025, it added a monthly per-patient fee for RPM-eligible services. Yet most US primary-care practices missed out on up to $647 000 a year in potential revenue, a sign that the billing landscape is still confusing (CMS analysis, 2025).

Key Takeaways

• RPM lets doctors monitor chronic patients from home.
• UnitedHealthcare is pulling back coverage for most conditions.
• Medicare still reimburses RPM under specific codes.
• Patients may face higher out-of-pocket costs.
• Consider alternative providers or private options.

Coverage rollback

Here’s the thing: UnitedHealthcare announced in late 2025 that it would cease RPM reimbursement for everything except a handful of “high-value” conditions. The decision came after internal reviews claimed “no robust evidence” that the technology reduced overall costs - a stance that runs contrary to the CDC’s findings that telehealth interventions lower hospital readmissions for chronic disease patients.

According to cmhealthlaw.com, the AMA’s CPT Editorial Panel had just approved new codes (99453-99457) that make RPM billing more straightforward. UnitedHealthcare’s pull-back effectively sidelines those codes for most of its members, leaving doctors to file “prior-authorization” paperwork for each remote check-in.

To illustrate the gap, see the comparison below:

The rollout has rippled through Australia’s expat community. A Melbourne-based cardiologist, Dr Sanjay Patel, told me that his US-based patients on UnitedHealthcare now face “double the paperwork” and higher out-of-pocket expenses. For locals on private health cover, the lesson is clear: insurers are watching RPM’s cost-effectiveness almost as closely as the government.

UnitedHealthcare did pause the decision in December 2025 after industry push-back, as reported by STAT. Yet the “pause” is more of a temporary hold - the policy is expected to resume once the insurer finalises its evidence review.

For Australian readers, the direct impact is limited unless you hold a US policy, but the episode signals that “coverage certainty” for telehealth may be more fragile than we hoped.

Patient impact

When I spoke to a Sydney renal-patient support group, several members shared stories of navigating RPM through private insurers. The common thread? A rise in cost and a scramble for alternative monitoring solutions.

Consider these practical effects:

1. Higher out-of-pocket bills: With UnitedHealthcare dropping reimbursement, patients now pay the full device price plus any data-plan fees.
2. Reduced clinician oversight: Doctors lose the automatic alerts that would flag a dangerous blood-pressure spike, meaning they must schedule more in-person visits.
3. Administrative burden: Prior authorisation forms add weeks to the start of a monitoring programme.
4. Equity gap: Rural patients, who benefit most from remote care, face the steepest cost climbs.
5. Potential for missed diagnoses: Without daily data, early signs of decompensation may be missed, increasing hospital admission rates.

The CDC’s recent briefing on telehealth interventions notes a 15% drop in readmission rates for COPD patients who used RPM, underscoring that the technology does have measurable health benefits.

In my years covering chronic disease, I’ve seen families panic when a monitoring patch is pulled. One Canberra family stopped their teenager’s asthma monitoring after their private insurer echoed UnitedHealthcare’s stance, leading to an ER visit that could have been avoided.

If you rely on RPM for disease management, the loss of coverage forces you to weigh three options:

• Self-funding: Purchase devices outright and absorb the data cost.
• Switch insurers: Look for policies that still honour RPM codes.
• Deviceless alternatives: Use phone-based check-ins, a cheaper albeit less data-rich solution.

Each choice carries trade-offs in cost, data fidelity and convenience. The key is to act before your next billing cycle, otherwise you could be hit with a surprise invoice.

Protect yourself

So, what can you do right now to shield yourself from the fallout?

1. Audit your policy: Pull up your UnitedHealthcare member portal and search “remote patient monitoring” to confirm which services remain covered.
2. Ask your doctor for CPT codes: The new AMA codes (99453-99457) are the linchpin for billing. If your provider can list them on the claim, you’re more likely to get reimbursed.
3. Negotiate a private-pay arrangement: Many clinics will discount the device fee if you agree to a bundled monthly rate.
4. Explore public-sector options: In NSW, the Telehealth Support Service offers subsidised RPM for eligible patients with chronic heart disease.
5. Consider deviceless RPM: Simple daily phone check-ins can be billed under “chronic care management” codes, which UnitedHealthcare still honours.
6. Document everything: Keep receipts for device purchases, data plans and any doctor-ordered monitoring. This paperwork will be crucial if you need to appeal a denied claim.
7. Stay informed: Subscribe to updates from the Australian Digital Health Agency - they publish quarterly reports on telehealth policy changes.
8. Join a patient advocacy group: Collective voices have successfully pressured insurers to reinstate coverage in past disputes.
9. Check for Medicare parallels: If you’re eligible for Australian Medicare, remember that it already funds certain home-monitoring devices for chronic disease management.
10. Plan for emergencies: Keep a backup in-person appointment schedule in case remote data stops flowing.

In my reporting, the most resilient patients are those who diversify their monitoring sources - a mix of insurer-covered devices, personal gadgets and clinician-led phone reviews.

Bottom line

UnitedHealthcare’s RPM rollback is a warning bell for anyone relying on remote monitoring to keep chronic illness in check. While Medicare in the US still recognises the service under specific CPT codes, private insurers are now tightening the purse strings.

Our recommendation: act now to avoid surprise costs and maintain clinical oversight.

1. Contact your insurer within the next two weeks to verify which RPM services remain covered and request written confirmation.
2. Arrange a telehealth consult with your GP to discuss alternative monitoring pathways - whether it’s a self-funded device, a deviceless programme, or a switch to a more RPM-friendly health fund.

By taking these steps, you’ll keep your chronic condition under control without letting a policy shift dictate your health outcomes.

FAQ

Q: What is remote patient monitoring (RPM)?

A: RPM is a set of technologies that let clinicians track patients’ health data - like blood pressure, glucose levels or weight - from home, using devices that automatically send readings to a secure platform.

Q: Why did UnitedHealthcare roll back RPM coverage?

A: UnitedHealthcare cited an internal review that found “no robust evidence” that RPM reduced overall costs, prompting the insurer to limit reimbursement to a narrow list of high-value conditions.

Q: Does Medicare still cover RPM?

A: Yes. Medicare continues to reimburse RPM under CPT codes 99453-99457 for eligible chronic conditions, provided the services meet documentation and physician-oversight requirements.

Q: How will the rollback affect Australian patients with US insurance?

A: Australians holding UnitedHealthcare policies will likely see higher out-of-pocket costs for RPM devices and may need to seek alternative monitoring methods or switch insurers to retain coverage.

Q: What are “deviceless” RPM options?

A: Deviceless RPM relies on regular phone or video check-ins, where clinicians assess symptoms and medication adherence without any hardware. It’s cheaper but offers less granular data.

Q: Where can I find Australian public-funded RPM programmes?

A: State health departments, such as NSW Health’s Telehealth Support Service, subsidise home monitoring for eligible chronic disease patients. Check your local health authority’s website for enrolment criteria.